IRWD compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name

IRWDIronwood Pharmaceuticals Inc

Mkt capRevenueRevenue

LLYELI Lilly & Co

Mkt capRevenueRevenue

Compare

IRWDIronwood Pharmaceuticals Inc

LLYELI Lilly & Co

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IRWD

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±31.0%▲+6.90%×0.22

Q2 FY26±15.6%▲+2.65%×0.17

May 7 '26±11.8%▼−13.66%×1.16

Q1 FY26±22.4%▼−11.35%×0.50

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

= impliedIRWD realized, solidLLY realized, hatchedOne scale, both sides: full bar = 32%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.3%

▲+9.80%

×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

IRWDIronwood Pharmaceuticals Inc

4.37▲+8.35%· post 4.30

Mkt cap$726.8MRevenue$133MQ3 FY26Revenue$296MFY25

LLYELI Lilly & Co

1,360.90▼−0.28%· post 1,358.90

ClosedNov 6 '26

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

Compare

ClosedNov 6 '26

IRWDIronwood Pharmaceuticals Inc

LLYELI Lilly & Co

4.37▲+8.35%post 4.30

Price

1,360.90▼−0.28%post 1,358.90

$726.8M

Mkt cap

$1.2T

Q3 FY26$133M

Revenue

$24.4BQ3 FY26

FY25$296M

Revenue

$65.2BFY25

IRWD4.37▲+8.35%vsLLY1,360.90▼−0.28%ClosedNov 6 '26